(Q43848095)

27 November 2017

title

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study (English)

1 reference

27 November 2017

1 reference

Chakrabarti S

1

1 reference

27 November 2017

Collingham KE

2

1 reference

27 November 2017

Holder K

3

1 reference

27 November 2017

Fegan CD

4

1 reference

27 November 2017

Osman H

5

1 reference

27 November 2017

Milligan DW

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Bone Marrow Transplantation

27 November 2017

published in

1 reference

27 November 2017

volume

28

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

759-763

1 reference

Respiratory virus infections in bone marrow transplant recipients: the European perspective

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Community respiratory virus infections in immunocompromised patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703216

21 January 2018

Identifiers

DOI

10.1038/SJ.BMT.1703216

1 reference

Dimensions Publication ID

27 November 2017

1017850063

0 references

1 reference